Literature DB >> 16901399

Mycosis fungoides and sezary syndrome: an update.

Ellen J Kim1, Julie Lin, Jacqueline M Junkins-Hopkins, Carmela C Vittorio, Alain H Rook.   

Abstract

Mycosis fungoides (MF), and the associated leukemic variant Sezary Syndrome (SS), are the most common group of cutaneous T-cell lymphomas. MF/SS is a non-Hodgkin's lymphoma of mature, skin-homing, clonal, malignant T lymphocytes that initially presents in the skin as patches, plaques, tumors, or generalized erythema (erythroderma) and can involve the lymph nodes and peripheral blood. Much progress has been made in recent years in understanding the origin of the malignant T cell in MF/SS and the pathophysiology and immunology of the disease. This recent work has made a great impact on diagnosis, prognostication, and treatment. In this review, we survey the MF/SS published literature over the past year and highlight some of the important advances.

Entities:  

Mesh:

Year:  2006        PMID: 16901399     DOI: 10.1007/s11912-006-0061-1

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  66 in total

1.  Association of change in clinical status and change in the percentage of the CD4+CD26- lymphocyte population in patients with Sézary syndrome.

Authors:  Camille E Introcaso; Stephen D Hess; Malek Kamoun; Ravi Ubriani; Joel M Gelfand; Alain H Rook
Journal:  J Am Acad Dermatol       Date:  2005-09       Impact factor: 11.527

2.  Is bone marrow biopsy necessary in patients with mycosis fungoides and Sézary syndrome? A histological and molecular study at diagnosis and during follow-up.

Authors:  M Beylot-Barry; M Parrens; M Delaunay; R Thiebault; B Vergier; A DeMascarel; P Dubus; C Beylot; J P Merlio
Journal:  Br J Dermatol       Date:  2005-06       Impact factor: 9.302

3.  CD25 expression is correlated with histological grade and response to denileukin diftitox in cutaneous T-cell lymphoma.

Authors:  Rakhshandra Talpur; Daniel M Jones; Alvaro J Alencar; Narin Apisarnthanarax; Kelly L Herne; Ying Yang; Madeleine Duvic
Journal:  J Invest Dermatol       Date:  2006-03       Impact factor: 8.551

4.  Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV.

Authors:  Maria Grazia Narducci; Enrico Scala; Antonella Bresin; Elisabetta Caprini; Maria Cristina Picchio; Daniele Remotti; Gianluca Ragone; Francesca Nasorri; Marina Frontani; Diego Arcelli; Stefano Volinia; Giuseppe Alfonso Lombardo; Giannandrea Baliva; Monica Napolitano; Giandomenico Russo
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

5.  Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study.

Authors:  Lorraine Tracey; Raquel Villuendas; Ana Maria Dotor; Inmaculada Spiteri; Pablo Ortiz; Juan F Garcia; Jose Luis Rodriguez Peralto; Mark Lawler; Miguel A Piris
Journal:  Blood       Date:  2003-04-10       Impact factor: 22.113

6.  Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides.

Authors:  Arturo Molina; Jasmine Zain; Daniel A Arber; Maria Angelopolou; Margaret O'Donnell; Joyce Murata-Collins; Stephen J Forman; Auayporn Nademanee
Journal:  J Clin Oncol       Date:  2005-09-01       Impact factor: 44.544

7.  Usefulness of cutaneous T-cell clonality analysis for the diagnosis of cutaneous T-cell lymphoma in patients with erythroderma.

Authors:  Nadege Cordel; Bernard Lenormand; Philippe Courville; Marie France Helot; Jacques Benichou; Pascal Joly
Journal:  Arch Pathol Lab Med       Date:  2005-03       Impact factor: 5.534

8.  Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sézary syndrome.

Authors:  M Sokolowska-Wojdylo; J Wenzel; E Gaffal; J Steitz; J Roszkiewicz; T Bieber; T Tüting
Journal:  Clin Exp Dermatol       Date:  2005-11       Impact factor: 3.470

9.  T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.

Authors:  R Ponti; P Quaglino; M Novelli; M T Fierro; A Comessatti; A Peroni; L Bonello; M G Bernengo
Journal:  Br J Dermatol       Date:  2005-09       Impact factor: 9.302

10.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

View more
  5 in total

1.  The histone deacetylase inhibitors vorinostat and romidepsin downmodulate IL-10 expression in cutaneous T-cell lymphoma cells.

Authors:  Ce Tiffon; Je Adams; L van der Fits; S Wen; Pa Townsend; A Ganesan; E Hodges; Mh Vermeer; G Packham
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

2.  Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalities.

Authors:  Filiberto Cedeno-Laurent; Elisha M Singer; Maria Wysocka; Bernice M Benoit; Carmela C Vittorio; Ellen J Kim; Gil Yosipovitch; Alain H Rook
Journal:  Clin Immunol       Date:  2015-03-08       Impact factor: 3.969

3.  Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases.

Authors:  Porcia T Bradford; Susan S Devesa; William F Anderson; Jorge R Toro
Journal:  Blood       Date:  2009-03-11       Impact factor: 22.113

4.  NBUVB Phototherapy at the Donor Site Can Enhance the Graft Uptake in the Nonhealing of Ulcers of Mycosis Fungoides: A Case Report.

Authors:  Imran Ahmad; Rajesh K Maurya; Sushama Sushama; Ali A Mahmud
Journal:  J Cutan Aesthet Surg       Date:  2019 Apr-Jun

5.  Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma.

Authors:  Britt Lauenborg; Louise Christensen; Ulrik Ralfkiaer; Katharina L Kopp; Lars Jønson; Sally Dabelsteen; Charlotte M Bonefeld; Carsten Geisler; Lise Mette R Gjerdrum; Qian Zhang; Mariusz A Wasik; Elisabeth Ralfkiaer; Niels Ødum; Anders Woetmann
Journal:  Oncotarget       Date:  2015-06-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.